Medical therapy for obesity: present and future.

Isr Med Assoc J

Endocrine Unit, Sapir Medical Center, Kfar Saba, Israel.

Published: December 2004

The prevalence of obesity worldwide has risen sharply during the last four decades. The etiology of obesity is complex and includes a host of genetic influences in addition to the overconsumption of energy coupled with a sedentary lifestyle. Obesity is known to cause or exacerbate many co-morbid conditions such as diabetes, hypertension, dyslipidemia, coronary heart disease, stroke, certain cancers, arthritis and obstructive sleep apnea. Modest weight losses of 5-10% of actual weight are related to significant improvements in co-morbid conditions, but unfortunately the rate of recidivism with short-term therapy for obesity is high. The recent recognition of obesity as a chronic disease that should be treated with long-term programs and possibly with polypharmacy, and the alarming increase in its prevalence, have prompted extensive research and the development of new pharmacotherapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

therapy obesity
8
co-morbid conditions
8
obesity
6
medical therapy
4
obesity future
4
future prevalence
4
prevalence obesity
4
obesity worldwide
4
worldwide risen
4
risen sharply
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!